Stockreport

CORRECTION - FDA GRANTS FAST TRACK DESIGNATION TO SACITUZUMAB GOVITECAN FOR LOCALLY-ADVANCED OR METASTATIC UROTHELIAL CANCER

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF MORRIS PLAINS, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today by Immunomedics, Inc. (Nasdaq:IMMU), the headline was inaccurate. The cancer [Read more]